New substances, new markets, new risks — understanding Europe’s changing drug landscape starts with solid facts. On 9 June, the European Union Drugs Agency (EUDA) will launch the European Drug Report 2026: Trends and Developments in Brussels, delivering the latest evidence on the state of the drugs problem in Europe. Drawing on data from 29 countries (EU-27, Norway and Türkiye), the comprehensive analysis covers drug use and supply as well as drug-related harms and responses.
The online report features over 100 graphics, including interactive dashboards, allowing readers to visualise data and trends at European and national level. It also provides open access to source data, making analysis, sharing and re-use easier for readers.
Alongside the report, the 2026 Statistical Bulletin provides national and city-level datasets.
For over 30 years, this flagship publication has helped policymakers and practitioners understand Europe’s evolving drug phenomenon.
Join us as we share the latest findings.
Press conference
Date: 9 June 2026 at 09:00 WEST (Lisbon), 10:00 CEST (Brussels) (time to be confirmed)
Location: European Commission (Berlaymont, VIP corner).
The press conference will be livestreamed on Europe by Satellite.
Speakers:
- Magnus Brunner, European Commissioner for Internal Affairs and Migration
- Franz Pietsch, Chair of the EUDA Management Board (Austria)
- Lorraine Nolan, Executive Director, EUDA
Further details will be available in the run-up to the launch at: https://www.euda.europa.eu/edr2026
Embargoed report and interviews: press@euda.europa.eu
